Shepherd Financial Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $786K | Buy |
4,130
+19
| +0.5% | +$3.27K | 0.06% | 136 |
|
|
2026
Q1 | $694K | Buy |
4,111
+2,847
| +225% | +$487K | 0.07% | 134 |
|
|
2025
Q4 | $213K | Buy |
+1,264
| New | +$205K | 0.02% | 235 |
|
|
2025
Q2 | – | Sell |
-6,746
| Closed | -$863K | – | 242 |
|
|
2025
Q1 | $863K | Buy |
6,746
+249
| +4% | +$33.8K | 0.1% | 112 |
|
|
2024
Q4 | $859K | Buy |
6,497
+48
| +0.7% | +$6.75K | 0.1% | 104 |
|
|
2024
Q3 | $939K | Buy |
6,449
+41
| +0.6% | +$5.93K | 0.11% | 103 |
|
|
2024
Q2 | $880K | Buy |
6,408
+26
| +0.4% | +$3.47K | 0.11% | 104 |
|
|
2024
Q1 | $876K | Buy |
6,382
+6
| +0.1% | +$819 | 0.11% | 108 |
|
|
2023
Q4 | $866K | Buy |
+6,376
| New | +$778K | 0.12% | 106 |
|
|
2023
Q1 | – | Sell |
-2,039
| Closed | -$268K | – | 180 |
|
|
2022
Q4 | $268K | Sell |
2,039
-48
| -2% | -$6.2K | 0.05% | 153 |
|
|
2022
Q3 | $244K | Sell |
2,087
-234
| -10% | -$29.1K | 0.05% | 147 |
|
|
2022
Q2 | $273K | Sell |
2,321
-5,370
| -70% | -$637K | 0.05% | 142 |
|
|
2022
Q1 | $999K | Sell |
7,691
-270
| -3% | -$35.2K | 0.18% | 89 |
|
|
2021
Q4 | $1.21M | Buy |
7,961
+105
| +1% | +$16.3K | 0.21% | 82 |
|
|
2021
Q3 | $1.27M | Buy |
7,856
+23
| +0.3% | +$3.87K | 0.24% | 75 |
|
|
2021
Q2 | $1.28M | Buy |
7,833
+1,229
| +19% | +$189K | 0.24% | 78 |
|
|
2021
Q1 | $994K | Buy |
6,604
+156
| +2% | +$24.8K | 0.22% | 85 |
|
|
2020
Q4 | $978K | Sell |
6,448
-115
| -2% | -$16.4K | 0.22% | 83 |
|
|
2020
Q3 | $889K | Buy |
6,563
+416
| +7% | +$56.4K | 0.21% | 80 |
|
|
2020
Q2 | $840K | Buy |
6,147
+138
| +2% | +$17.6K | 0.23% | 68 |
|
|
2020
Q1 | $648K | Sell |
6,009
-869
| -13% | -$100K | 0.22% | 72 |
|
|
2019
Q4 | $830K | Hold |
6,878
| – | – | 0.19% | 73 |
|
|
2019
Q3 | $686K | Sell |
6,878
-402
| -6% | -$42.1K | 0.17% | 76 |
|
|
2019
Q2 | $794K | Hold |
7,280
| – | – | 0.15% | 74 |
|
|
2019
Q1 | $814K | Buy |
7,280
+3,093
| +74% | +$339K | 0.16% | 69 |
|
|
2018
Q4 | $400K | Sell |
4,187
-7,950
| -66% | -$844K | 0.09% | 93 |
|
|
2018
Q3 | $1.33M | Hold |
12,137
| – | – | 0.3% | 51 |
|
|
2018
Q2 | $1.34M | Buy |
12,137
+1,978
| +19% | +$212K | 0.3% | 51 |
|
|
2018
Q1 | $1.08M | Sell |
10,159
-446
| -4% | -$49.4K | 0.27% | 48 |
|
|
2017
Q4 | $1.14M | Buy |
10,605
+3,801
| +56% | +$406K | 0.27% | 49 |
|
|
2017
Q3 | $767K | Buy |
6,804
+2,562
| +60% | +$274K | 0.18% | 68 |
|
|
2017
Q2 | $436K | Buy |
+4,242
| New | +$418K | 0.11% | 83 |
|
Other funds holding IBB
CB
Shepherd Financial Partners's IBB Position: Q2 2026 in Review
Shepherd Financial Partners increased its iShares Biotechnology ETF (IBB) stake by 0.46% in Q2 2026, buying an estimated $3.27K and bringing the position to 4,130 shares worth $786K. The position accounts for 0.06% of the portfolio, ranked #136.
Shepherd Financial Partners first reported a position in IBB in Q2 2017 and has held it in 32 quarters since. The position peaked at $1.34M in Q2 2018. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Shepherd Financial Partners held 4,130 shares of iShares Biotechnology ETF worth $786K as of Q2 2026.
- Shepherd Financial Partners bought 19 iShares Biotechnology ETF shares in Q2 2026, an estimated $3.27K.
- iShares Biotechnology ETF made up 0.06% of Shepherd Financial Partners's portfolio in Q2 2026, its #136 holding.
- Shepherd Financial Partners first reported a position in iShares Biotechnology ETF in Q2 2017 and has held it in 32 quarters since.
- Shepherd Financial Partners's iShares Biotechnology ETF position peaked at $1.34M in Q2 2018.
- 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Shepherd Financial Partners's 13F filing for Q2 2026, filed 10 Aug 2026.